FibroDynamx Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

FibroDynamx General Information

Description

Developer of a drug discovery platform designed to develop anti-fibrotic and regenerative therapies by studying scar-free healing in reindeer antler skin. The company offers a biologically inspired de-risking approach, advanced target validation tools, and preclinical models that replicate regenerative skin repair, enabling researchers and pharmaceutical developers to identify treatments that improve healing and reduce scar formation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Calgary, Alberta
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Corporate Office
  • Calgary, Alberta
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FibroDynamx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 25-Nov-2025 Completed Generating Revenue
2. Accelerator/Incubator 16-Oct-2025 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
To view FibroDynamx’s complete valuation and funding history, request access »

FibroDynamx Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capital BioVentures Accelerator/Incubator
Life Sciences BC Accelerator/Incubator
Creative Destruction Lab Accelerator/Incubator
To view FibroDynamx’s complete investors history, request access »

FibroDynamx FAQs

  • When was FibroDynamx founded?

    FibroDynamx was founded in 2024.

  • Where is FibroDynamx headquartered?

    FibroDynamx is headquartered in Calgary, Canada.

  • What industry is FibroDynamx in?

    FibroDynamx’s primary industry is Drug Discovery.

  • Is FibroDynamx a private or public company?

    FibroDynamx is a Private company.

  • What is FibroDynamx’s current revenue?

    The current revenue for FibroDynamx is .

  • Who are FibroDynamx’s investors?

    Capital BioVentures, Life Sciences BC, and Creative Destruction Lab have invested in FibroDynamx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process